Hikma Pharmaceuticals PLC
HKMPY · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $5,534 | $5,049 | $4,133 | $6,959 |
| - Cash | $188 | $205 | $270 | $426 |
| + Debt | $1,306 | $1,191 | $1,283 | $846 |
| Enterprise Value | $6,652 | $6,035 | $5,146 | $7,379 |
| Revenue | $3,127 | $2,875 | $2,517 | $2,553 |
| % Growth | 8.8% | 14.2% | -1.4% | – |
| Gross Profit | $1,415 | $1,407 | $1,238 | $1,301 |
| % Margin | 45.3% | 48.9% | 49.2% | 51% |
| EBITDA | $727 | $559 | $688 | $766 |
| % Margin | 23.2% | 19.4% | 27.3% | 30% |
| Net Income | $359 | $190 | $188 | $421 |
| % Margin | 11.5% | 6.6% | 7.5% | 16.5% |
| EPS Diluted | 3.22 | 1.72 | 1.68 | 3.62 |
| % Growth | 87.2% | 2.4% | -53.6% | – |
| Operating Cash Flow | $564 | $608 | $530 | $638 |
| Capital Expenditures | -$235 | -$204 | -$225 | -$229 |
| Free Cash Flow | $329 | $404 | $305 | $409 |